
| CARDIFF: APRIL 2010 | |
Christopher Wood to present at Wales Cancer Conference in Cardiff, 14th - 15th April 2010. |
|
| Link to further details | |
![]() |
|
| EDINBURGH: FEBRUARY 2010 | |
Hugh Griffith to present at BIA Scotland BioLeadership Forum and Dinner, 4th February 2010. |
|
| Link to further details | |
| EDINBURGH: 18 December 2009 | |
| NuCana BioMed Completes Financing to Expand Anti-Cancer Drug Development Programme | |
NuCana BioMed Ltd ("NuCana") today announced it had completed a further equity financing that will allow the company to rapidly expand its drug development programme of new anti-cancer agents. |
|
| Links to full story | |
![]() |
EDINBURGH: 18 December 2009 |
| Alida Capital International Completes Financing into NuCana BioMed | |
| Alida Capital International Ltd ("Alida") today announced it had completed an equity financing into Edinburgh based biopharmaceutical company NuCana BioMed ("NuCana"). The Scottish Enterprise Scottish Co-Investment Fund participated in the round. | |
| Links to full story | |
| CARDIFF: 18 November 2009 | |
| Morvus Technology and NuCana BioMed sign exclusive world-wide licence to develop ProTide Technology in Cancer | |
| Morvus Technology Ltd ("Morvus") and NuCana BioMed Ltd ("NuCana") today announce that an agreement has been signed by which Morvus has granted to NuCana an exclusive, world-wide, licence with rights to develop its ProTide technology for the enhancement of nucleoside analogues ("nucleosides"). | |
| Links to full story | |